Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas

American Journal of Clinical Pathology

Volumn 138, Issue 5, 2012, Pages 703-711

  Mukhopadhyay, Sanjay ^a   Katzenstein, Anna Luise A ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Adenocarcinoma; Carcinoma; Lung; Metastatic; Monoclonal; Napsin A; Polyclonal; TTF 1

Indexed keywords

ASPARTIC PROTEINASE; MONOCLONAL ANTIBODY; MONOCLONAL NAPSIN A; POLYCLONAL ANTIBODY; POLYCLONAL NAPSIN A; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ADRENAL METASTASIS; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CONTROLLED STUDY; DISTANT METASTASIS; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN TISSUE; KIDNEY METASTASIS; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKIN METASTASIS; THYROID CARCINOMA; THYROID METASTASIS; TRANSITIONAL CELL CARCINOMA;

ADENOCARCINOMA; ANTIBODIES; ASPARTIC ACID ENDOPEPTIDASES; DNA-BINDING PROTEINS; HUMANS; LUNG; LUNG NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84868091619     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPKVBXTI9O3TEM     Document Type: Article

References (26)

1. Hecht JL, Pinkus JL, Weinstein LJ, et al. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol. 2001;116:483-488. (Pubitemid 34450281)
2. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology. 2000;36:8-16. (Pubitemid 30055417)
3. Bohinski RJ, Bejarano PA, Balko G, et al. Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1. J Neurooncol. 1998;40:227-231. (Pubitemid 29054658)
4. Strickland-Marmol LB, Khoor A, Livingston SK, et al. Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain. Arch Pathol Lab Med. 2007;131:1686-1690. (Pubitemid 350077466)
5. Bejarano PA, Nikiforov YE, Swenson ES, et al. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol. 2000;8:189-194.
6. Compérat E, Zhang F, Perrotin C, et al. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Mod Pathol. 2005;18:1371-1376. (Pubitemid 41348657)
7. Matoso A, Singh K, Jacob R, et al. Comparison of thyroid transcription factor-1 by two monoclonal antibodies in pulmonary and non-pulmonary primary tumors. Appl Immunohistochem Mol Morphol. 2010;18:142-149.
8. Robens J, Goldstein L, Gown AM, et al. Thyroid transcription factor-1 expression in breast carcinomas. Am J Surg Pathol. 2010;34:1881-1885.
9. Bishop JA, Sharma R, Illei PB. Napsin A and TTF-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol. 2010;41:20-25.
10. Yang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol. 2010;23:654-661.
11. Zhang K, Liu H, Zhu S, et al. Expression of napsin A in carcinomas from various organs [abstract]. Mod Pathol. 2011;24(suppl 1):430A.
12. Penman D, Downie I, Roberts F. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution. J Clin Pathol. 2006;59:663-664. (Pubitemid 43886055)
13. Ye J, Findeis-Hosey JJ, Yang Q, et al. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl Immunohistochem Mol Morphol. 2011;19:313-317.
14. Zhang PJ, Gao HG, Pasha TL, et al. TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Int J Gynecol Pathol. 2008;28:10-18.
15. Graham AD, Williams AR, Salter DM. TTF-1 expression in primary ovarian epithelial neoplasia. Histopathology. 2006;48:764-765.
16. Siami K, McCluggage WG, Ordonez NG, et al. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am J Surg Pathol. 2007;31:1759-1763.
17. Bisceglia M, Galliani C, Rosai J. TTF-1 expression in breast carcinoma - the chosen clone matters. Am J Surg Pathol. 2011;35:1087-1088.
18. Zhang PJ, Gao HG, Pasha TL, et al. TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Int J Gynecol Pathol. 2009;28:10-18.
19. Hirano T, Gong Y, Yoshida K, et al. Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma. Lung Cancer. 2003;41:155-162. (Pubitemid 36842778)
20. Mizutani Y, Nakajima T, Morinaga S, et al. Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors: special reference to nonmucus producing lung adenocarcinomas. Cancer. 1988;61:532-537. (Pubitemid 18039368)
21. Suzuki A, Shijubo N, Yamada G, et al. Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs. Pathol Res Pract. 2005;201:579-586. (Pubitemid 41363952)
22. Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63 and CK5/6. Am J Surg Pathol. 2011;35:15-25.
23. Righi L, Graziano P, Fornari A, et al. Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation. Cancer. 2011;117:3416-3423.
24. Stoll LM, Johnson MW, Gabrielson E, et al. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas. Cancer Cytopathol. 2010;118:441-449.
25. Dejmek A, Naucler P, Smedjenack A, et al. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Diagn Cytopathol. 2007;35:493-497. (Pubitemid 47267511)
26. Ordoñez NG. Napsin A expression in lung and kidney neoplasia: a review and update. Adv Anat Pathol. 2012;19:66-73.